{
    "2021-06-19": [
        [
            {
                "time": "2021-06-19",
                "original_text": "医药龙头药明康德股东偷偷减持29亿 证监会最新发声：依法处理！ 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东减持",
                        "证监会",
                        "依法处理"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "证券市场禁入新规下月实施 资本市场违法违规零容忍",
                "features": {
                    "keywords": [
                        "证券市场",
                        "禁入新规",
                        "资本市场",
                        "违法违规"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "医药行业周报：国内首个CAR-T即将获批 如何看CGT领域未来？",
                "features": {
                    "keywords": [
                        "医药行业",
                        "CAR-T",
                        "CGT领域",
                        "获批"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "细胞疗法新秀Lyllel登录纳斯达克：市值超39亿美元，高瓴、红杉、药明康德为股东",
                "features": {
                    "keywords": [
                        "细胞疗法",
                        "Lyllel",
                        "纳斯达克",
                        "药明康德"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "证监会问答，涉ST中安、康得新、药明康德等",
                "features": {
                    "keywords": [
                        "证监会",
                        "ST中安",
                        "康得新",
                        "药明康德"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "“偷偷”减持29亿惹众怒 药明康德这位股东什么来头？记者探访注册地 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东减持",
                        "偷偷",
                        "注册地"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "17个药品被禁用，招采违规遭严打，知名药企掀裁员潮，科伦、齐鲁...27个注射剂集采中标 其他违规处罚",
                "features": {
                    "keywords": [
                        "药品禁用",
                        "招采违规",
                        "裁员潮",
                        "集采中标"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "迷茫期的一张投资明牌",
                "features": {
                    "keywords": [
                        "投资明牌",
                        "迷茫期"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "百时美施贵宝31亿美元合作开发，这款ADC有何独特之处？",
                "features": {
                    "keywords": [
                        "百时美施贵宝",
                        "ADC",
                        "合作开发"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "速递 | 23亿美元助力开发即用型自然杀伤细胞疗法，Kite公司达成合作",
                "features": {
                    "keywords": [
                        "自然杀伤细胞疗法",
                        "Kite公司",
                        "合作"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-19",
                "original_text": "前沿 | 克服PARP抑制剂耐药性，“老”抗生素展现“新”抗癌潜力",
                "features": {
                    "keywords": [
                        "PARP抑制剂",
                        "抗生素",
                        "抗癌潜力"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}